National Patterns of Early Adoption of Magnetic Resonance Imaging-Guided Linear Accelerators in 2018 to 2019.

ABSTRACT:

Purpose

Adaptive magnetic resonance imaging-guided linear accelerators (aMRI-LINACs) are an emerging technology with the potential to improve radiation treatment for cancer through improved visualization and adaptive treatment. Given the competing forces of the increased cost, knowledge, and staff required for aMRI-LINAC therapy, it is unpredictable how rapidly and for whom aMRI-LINAC therapy is being adopted. Therefore, given that aMRI-LINAC therapy was granted approval from the Food and Drug Administration in late 2017, we evaluated the National Cancer Database (NCDB) to obtain a nationwide view of early aMRI-LINAC adoption in 2018 to 2019.

Methods and materials

Forty-three disease sites were aggregated. A sample of patients who underwent intensity modulated radiation ther

SUBMITTER: Yu JB 

PROVIDER: S-EPMC9926207 | biostudies-literature | 2023 May-Jun

REPOSITORIES: biostudies-literature